Global Hospital Acquired Infection Control Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

In this report, the Hospital Acquired Infection Control Market has been segmented by Product, Indications, End Users and Geography.

Hospital Acquired Infection Control Market, Segmentation by Product

The Hospital Acquired Infection Control Market has been segmented by Product into Sterilants - Heat Sterilization Equipment, Low Temperature Sterilization Equipment, Radiation Sterilization Equipment and Other Sterilants, Disinfectants and Other Products.

Heat Sterilization Equipment

Heat sterilization equipment, such as autoclaves and dry heat ovens, remains a key tool for infection control, particularly for sterilizing heat-resistant medical instruments. Its proven effectiveness in eliminating a wide range of pathogens supports its extensive use in healthcare. This segment continues to hold a prominent position due to its cost-effectiveness and reliability.

Low Temperature Sterilization Equipment

Low temperature sterilization is essential for processing delicate medical devices, utilizing methods such as hydrogen peroxide gas plasma and ethylene oxide. In 2023, this segment represented approximately 35% of the global sterilization equipment market, highlighting its growing importance in modern infection control. The rising complexity of medical devices further supports its adoption.

Radiation Sterilization Equipment

Radiation sterilization employs gamma rays, electron beams, or X-rays to sterilize disposable medical supplies and pharmaceuticals. It is particularly valuable for items that are sensitive to heat or chemicals. The segment is witnessing steady growth, driven by increasing demand for single-use medical supplies and stringent regulatory requirements.

Other Sterilants

This category includes chemical sterilization agents such as ethylene oxide and peracetic acid, widely used for materials sensitive to heat and moisture. Ethylene oxide alone accounts for sterilizing over 50% of disposable medical devices, underlining its crucial role in infection control. These methods ensure the sterility of complex and delicate medical equipment.

Disinfectants

Disinfectants are essential for decontaminating surfaces and instruments, reducing the risk of hospital-acquired infections. The global disinfectants market is expected to grow steadily, with hospitals comprising a major share due to the need for stringent hygiene protocols. The rising focus on infection prevention is propelling demand for effective disinfectants.

Other Products

This segment includes products such as protective barriers, antimicrobial coatings, and endoscope reprocessing systems. In 2023, protective barriers, including gloves and gowns, dominated the infection control market with a share of approximately 62.73%. Continuous innovation in this category supports comprehensive infection prevention strategies in healthcare environments.

Hospital Acquired Infection Control Market, Segmentation by Indications

The Hospital Acquired Infection Control Market has been segmented by Indications into Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections and Other Indications.

Hospital Acquired Pneumonia

Hospital-acquired pneumonia (HAP) is responsible for approximately 15–20% of all hospital-acquired infections and is a leading contributor to hospital-associated mortality. It is particularly prevalent in intensive care units, accounting for nearly 25% of all infections in these settings. Implementing robust infection control measures is crucial to reducing HAP incidence and associated complications.

Bloodstream Infections

Bloodstream infections (BSIs) represent around 14% of hospital-acquired infection cases, with a high risk of severe outcomes, particularly in patients with weakened immune systems. These infections are often linked to central line use and can lead to increased hospital stays and healthcare costs. Adopting stringent infection prevention protocols is essential to minimizing BSI rates.

Surgical Site Infections

Surgical site infections (SSIs) are among the most frequent hospital-acquired infections, accounting for approximately 20% of cases. Infection rates vary by procedure type, from as low as 0.6% in knee prosthesis surgeries to as high as 9.5% in open colon surgeries. Strict adherence to sterile techniques and postoperative care protocols is critical to mitigating SSI risk.

Gastrointestinal Infections

Gastrointestinal infections, including those caused by Clostridioides difficile, make up about 17% of hospital-acquired infections. These infections are often linked to antibiotic use and can result in serious complications if not managed properly. Antimicrobial stewardship and stringent hygiene practices are key to reducing the prevalence of gastrointestinal infections in healthcare settings.

Urinary Tract Infections

Urinary tract infections (UTIs) are the most prevalent type of hospital-acquired infection, accounting for roughly 32% of all cases. Most UTIs are associated with the use of indwelling urinary catheters. Limiting unnecessary catheter use and ensuring proper care and maintenance are essential strategies to lower UTI rates in hospital environments.

Other Indications

This category includes a variety of infections such as skin and soft tissue infections, non-central line-associated bloodstream infections, and respiratory infections excluding pneumonia. Though individually representing smaller percentages, collectively they add significantly to the overall burden of hospital-acquired infections. Comprehensive and tailored infection control strategies are crucial to addressing these diverse infection types.

Hospital Acquired Infection Control Market, Segmentation by End Users

The Hospital Acquired Infection Control Market has been segmented by End Users into Hospitals and Intensive Care Units, Ambulatory Surgical and Diagnostic Centers, Nursing Homes and Maternity Centers and Other End Users.

Hospitals and Intensive Care Units

Hospitals and Intensive Care Units (ICUs) account for approximately 45.8% of the global Hospital Acquired Infection Control Market in 2023. The high incidence of hospital-acquired infections (HAIs) in these settings, driven by factors like increased patient volumes, invasive procedures, and vulnerable populations, necessitates comprehensive infection prevention strategies. Continuous monitoring and staff training are essential to mitigate infection risks in these high-pressure environments.

Ambulatory Surgical and Diagnostic Centers

Ambulatory Surgical and Diagnostic Centers are emerging as a growing segment, with a projected CAGR of 5.77% through the forecast period. The increase in outpatient procedures, combined with a need for cost-effective healthcare solutions, is boosting demand for advanced sterilization and disinfection technologies. Stringent infection control protocols are crucial to ensuring patient safety in these high-turnover environments.

Nursing Homes and Maternity Centers

Nursing Homes and Maternity Centers contribute approximately 12% of the global market, reflecting their vital role in infection control. The presence of high-risk populations, including elderly residents and newborns, necessitates vigilant hygiene practices and adherence to infection prevention guidelines. Training healthcare providers and ensuring compliance with regulatory standards are key to reducing infection risks in these settings.

Other End Users

This category includes outpatient clinics, rehabilitation centers, and home healthcare providers. While each represents a smaller share of the overall market, together they highlight the importance of a comprehensive approach to infection prevention. These settings are increasingly adopting tailored infection control solutions to protect patients and staff, contributing to the broader effort to reduce HAIs across all care environments.

Hospital Acquired Infection Control Market, Segmentation by Geography

In this report, the Hospital Acquired Infection Control Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Hospital Acquired Infection Control Market Share (%), by Geographical Region

North America

North America leads the Hospital Acquired Infection Control Market, accounting for approximately 35.2% of global revenue in 2023. This strong market position is driven by a high incidence of hospital-acquired infections (HAIs) and strict infection control protocols enforced across healthcare facilities. The region’s advanced healthcare infrastructure and proactive regulatory frameworks contribute to its continued dominance.

Europe

Europe holds a significant share of the global market, with countries like the UK and Germany at the forefront of adopting advanced infection prevention solutions. Growing financial pressure to manage HAI-related healthcare costs is prompting widespread adoption of innovative sterilization and disinfection technologies. The European market is projected to expand at a CAGR of 14.6% from 2023 to 2030.

Asia Pacific

Asia Pacific is witnessing robust growth in the Hospital Acquired Infection Control Market, driven by rising HAI awareness and expanding healthcare infrastructure. Valued at USD 9.44 billion in 2023, the market is expected to reach USD 28.88 billion by 2030, reflecting a CAGR of 15.0%. Investments by countries such as India and China in advanced infection prevention measures are accelerating market growth.

Middle East and Africa

The Middle East and Africa region is experiencing steady market growth, with a value of USD 404.73 million in 2022 projected to reach USD 830.43 million by 2030, expanding at a CAGR of 9.4%. Increasing surgical procedures, heightened awareness of infection prevention strategies, and improved access to healthcare are key drivers fueling market expansion in this region.

Latin America

Latin America holds a smaller but growing share of the global market, supported by efforts in countries like Brazil and Mexico to enhance infection control practices. Investments aimed at strengthening healthcare infrastructure and raising awareness of HAIs among healthcare providers are contributing to market growth across the region.

This report provides an in depth analysis of various factors that impact the dynamics of Global Hospital Acquired Infection Control Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers

• Increasing awareness, regulations
• Technological advancements, innovation
• Rising prevalence, healthcare-associated infections
• Growing healthcare expenditure

• Emphasis on infection prevention: In recent years, there has been a significant emphasis on infection prevention within healthcare facilities worldwide, driving the growth of the global Hospital Acquired Infection (HAI) Control Market. Hospital-acquired infections pose a serious threat to patient safety, prolonging hospital stays, increasing healthcare costs, and even leading to fatalities. As a result, healthcare providers are increasingly investing in infection control measures and technologies to mitigate the risk of HAIs. This has fueled the demand for a wide range of products and solutions, including disinfectants, sterilization equipment, surveillance systems, and antimicrobial textiles, among others. Additionally, stringent regulatory guidelines and initiatives by healthcare organizations to improve patient outcomes and reduce the burden of healthcare-associated infections further propel market growth.

  The global market for hospital-acquired infection control is characterized by intense competition among key players striving to innovate and introduce advanced solutions. Technological advancements such as the development of antimicrobial coatings, ultraviolet disinfection systems, and advanced sterilization techniques are driving market expansion. Moreover, the increasing adoption of healthcare information technology solutions for infection surveillance and control, coupled with rising awareness among healthcare professionals and patients regarding the importance of infection prevention, is bolstering market growth. With healthcare-associated infections remaining a significant challenge for healthcare systems worldwide, the Hospital Acquired Infection Control Market is poised for continued expansion in the coming years.

Restraints

• High cost, limited budgets
• Resistance to antimicrobial agents
• Lack of skilled professionals
• Stringent regulatory requirements

• Economic downturns, uncertainties: During economic downturns and periods of uncertainty, the healthcare industry often faces unique challenges. However, one sector that tends to maintain stability and even see growth is the market for hospital-acquired infection control. This is largely due to the heightened awareness and increased focus on preventing healthcare-associated infections (HAIs) during such times. Hospitals and healthcare facilities prioritize infection control measures to safeguard patients, staff, and visitors, leading to sustained demand for infection control products and services. Additionally, government regulations and healthcare policies often emphasize the importance of infection prevention, further driving investments in this market segment.

  The global hospital-acquired infection control market encompasses a wide range of products and solutions designed to mitigate the risk of HAIs in healthcare settings. These include disinfectants, sterilization equipment, surveillance systems, and personal protective equipment (PPE), among others. As hospitals strive to maintain high standards of patient care and safety, they invest in advanced technologies and innovative strategies to prevent infections and minimize transmission risks. Furthermore, the emergence of multidrug-resistant pathogens and infectious disease outbreaks underscores the critical need for effective infection control measures, propelling ongoing research and development efforts in this field. Despite economic uncertainties, the hospital-acquired infection control market is expected to exhibit resilience and steady growth driven by persistent demand for infection prevention solutions worldwide.

Opportunities

• Emerging markets, untapped potential
• Development of novel products
• Collaborations, partnerships
• Focus on patient safety

• Integration of AI, IoT: The integration of artificial intelligence (AI) and the Internet of Things (IoT) has significantly revolutionized hospital acquired infection control, offering advanced solutions to monitor, detect, and prevent infections more effectively. AI algorithms can analyze vast amounts of data collected from IoT devices such as sensors, wearable gadgets, and connected medical equipment in real-time. These algorithms can identify patterns, predict potential outbreaks, and provide actionable insights to healthcare professionals, enabling proactive measures to mitigate infection risks. For instance, AI-powered predictive analytics can forecast patient admissions, allowing hospitals to allocate resources efficiently and implement preemptive infection control strategies.

  In the global Hospital Acquired Infection Control Market, this integration has spurred remarkable growth and innovation. The market is witnessing a surge in demand for AI and IoT-based solutions as healthcare facilities prioritize infection prevention and patient safety. Technologies like smart disinfection systems, patient monitoring devices, and AI-driven analytics platforms are gaining traction, driving market expansion. Moreover, the COVID-19 pandemic has further accelerated the adoption of these technologies, with hospitals investing in advanced infection control solutions to combat the spread of the virus. As healthcare providers increasingly recognize the value of AI and IoT in infection control, the market is projected to experience continued growth, with a focus on enhancing operational efficiency and patient outcomes.

Key players in Global Hospital Acquired Infection Control Market include:

• 3M Company
• Becton, Dickinson and Company
• Belimed AG
• Biomerieux Sa
• Cantel Medical
• Ethicon
• Getinge Group
• Kimberly-Clark Corporation
• Sterigenics International LLC
• Steris Corporation

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis